Laboratory of Jeffrey R. Schneider, PhD

Our work

Dr. Schneider’s lab focuses on HIV antibody distribution.  He has helped develop a platform to track intravenous injected fluorophore conjugated IgG in plasma, tissue, and weck-cel fluid.  This methodology has led to a grant to study how the timing of antibody injection affects distal site accumulation of virus following challenge.  Through a better understanding of how antibodies get to and fortify mucosal surfaces from incoming pathogens, this research has the potential to elucidate novel HIV prevention strategies with the ultimate goal of blocking initial HIV transmission.  This work will help inform future passive immunization studies, such as the AMP (Antibody Mediated Prevention) trial which is currently underway and administering anti-HIV antibodies to at-risk individuals around the world.

Back to top

Impact of work


Back to top

Technology


Back to top

Funding

NIH K01OD024882: “The role of steady state broadly neutralizing antibody tissue levels in preventing distal site SHIV replication.

Back to top

Our team

  • Michelle Ash, PhD student (Rush)
  • Anjelica Reyes, MS student (Rush)
  • Pranjal Sharma, MS student (Roosevelt)

Back to top

Contact us

We welcome inquiries about our research, collaborations and funding. Please contact Jeffrey R. Schneider, PhD.

Back to top